Viewing Study NCT05177068


Ignite Creation Date: 2025-12-24 @ 5:31 PM
Ignite Modification Date: 2025-12-27 @ 12:20 PM
Study NCT ID: NCT05177068
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-10-02
First Post: 2021-12-15
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Conversion Therapy of Fruquintinib in Combination With Sintilimab and SOX in Unresectable Gastric Cancer
Sponsor: Henan Cancer Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module